Naftifine Hydrochloride Gel
Product Images NDC 51672-1376

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naftifine Hydrochloride (NDC 51672-1376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Naftifine 01)

Chemical structure diagram of Naftifine Hydrochloride, showing the molecular arrangement including benzene rings and the hydrochloride component.*

FDA Label Image

Principal Display Panel (60 g Tube Carton)

Naftifine Hydrochloride Gel USP, 2%, topical gel in a 60 g tube. The label indicates it is for topical use only, not for ophthalmic, oral, or intravaginal use. The product is manufactured by Taro Pharmaceuticals and distributed by Taro Pharmaceuticals U.S.A., Inc. The label also lists inactive ingredients and storage instructions, with a warning to keep medications out of the reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.